Next Article in Journal
Effects of Underwater Friction Stir Welding Heat Generation on Residual Stress of AA6068-T6 Aluminum Alloy
Previous Article in Journal
Attachment and Osteogenic Potential of Dental Pulp Stem Cells on Non-Thermal Plasma and UV Light Treated Titanium, Zirconia and Modified PEEK Surfaces
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Materials
Volume 15
Issue 6
10.3390/ma15062229
materials-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Graphene-Oxide-Enriched Biomaterials: A Focus on Osteo and Chondroinductive Properties and Immunomodulation

by
Alessia Ricci
,
Amelia Cataldi
,
Susi Zara
and
Marialucia Gallorini
*
Department of Pharmacy, “G. d'Annunzio” University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy
*
Author to whom correspondence should be addressed.
Materials 2022, 15(6), 2229; https://doi.org/10.3390/ma15062229
Submission received: 27 December 2021 / Revised: 28 February 2022 / Accepted: 14 March 2022 / Published: 17 March 2022
(This article belongs to the Special Issue Carbon/Graphene-Enriched Biomaterials and Applications)
Browse Figures
Versions Notes

Abstract

Due to its exceptional physical properties, such as high electronic conductivity, good thermal stability, excellent mechanical strength, and chemical versatility, graphene has sparked a lot of interest in the scientific community for various applications. It has therefore been employed as an antibacterial agent, in photothermal therapy (PTT) and biosensors, in gene delivery systems, and in tissue engineering for regenerative purposes. Since it was first discovered in 1947, different graphene derivatives have been synthetized from pristine graphene. The most adaptable derivate is graphene oxide (GO). Owing to different functional groups, the amphiphilic structure of GO can interact with cells and exogenous or endogenous growth/differentiation factors, allowing cell adhesion, growth, and differentiation. When GO is used as a coating for scaffolds and nanomaterials, it has been found to enhance bone, chondrogenic, cardiac, neuronal, and skin regeneration. This review focuses on the applications of graphene-based materials, in particular GO, as a coating for scaffolds in bone and chondrogenic tissue engineering and summarizes the most recent findings. Moreover, novel developments on the immunomodulatory properties of GO are reported.

1. Introduction

Graphene, a two-dimensional monolayer sheet of sp2-hybridized carbon atoms bounded covalently to form a hexagonal network, has attracted tremendous attention and research interest owing to its exceptional physical properties, such as high electronic conductivity, good thermal stability, and excellent mechanical strength [1,2]. Discovered in 1947 [3], graphene and its derivatives have been explored for a wide range of applications, such as electronic and photonic devices, clean energy, and sensors [4].
There are two major fabrication methods related to graphene, defined as top-down and bottom-up procedures. The first method is based on exfoliation of the hexagonal 3D graphite reticulum of graphene to obtain 2D or 1D graphene layers. The second method uses the assembly of a single atom or molecules to accomplish 1D or 2D arrangements in graphene layers [5]. Liquid-phase exfoliation (LPE) of graphite is the best approach to obtain graphene in a large scale and at an economic price. This method is based on the capability of graphite to be dispersed in a specific organic solvent. By applying external forces, such as sonication or rapid agitation, van der Waals forces between graphene sheets break down, and a single purified monolayer can be obtained. This process can be even more improved by using surfactants [6]. Starting from pristine raw graphene, different derivatives have been synthetized, among which the most versatile are graphene oxide (GO), reduced graphene oxide (rGO), nanographenes (NGs), and graphene nanoribbons [7]. GO results from the chemical exfoliation and oxidation of layered crystalline graphite, while rGO is derived from the removal of oxygen groups from GO by reducing chemical agents, such as hydrazine, ascorbic acid, and many others, or through thermal or UV treatment of GO [8].
GO presents different functional groups (Figure 1), such as hydroxyl and carboxylic groups in the edges and epoxy groups in the basal planes as well as phenol and lactone groups. Because of this structure, GO possesses better amphiphilic characteristics than pristine graphene. As a matter of fact, its hydroxylic and epoxy groups can establish hydrogen bonds, thereby making it dispersible in water or polar solvents. Moreover, its carbonic skeleton can interact with lipophilic groups [9]. The amphiphilic features of GO are essential for its biological usage. It has therefore broadly been reported that GO-coated materials support cell adhesion, growth, and differentiation [10]. Due to its attributes, GO has been reported to be capable of interfacing and co-operating with cells, growth factors, and hydrophilic substrates to improve the biocompatibility of several cell supports for regenerative purposes (Table 1) [11,12].
Over 10 years have passed since a single-layer graphene was exfoliated from highly oriented pyrolytic graphite [13], although research in this field is still broadly active. Thanks to its multiple properties and chemical versatility, there are several applications for graphene and its derivatives, and a plethora of research works have been made available in the last decade [14]. This review aims at summarize the main biomedical applications of GO-based materials with a particular focus on their osteoinductive and chondroinductive capabilities.

2. Biomedical Applications of GO

Due to their exceptional properties, GO-based materials are nowadays investigated as biosensors [15], antibacterial agents [16], in photothermal therapy (PTT) [17], as gene delivery systems [18], and for applications in tissue engineering and regenerative medicine [19] (Figure 2A). Among all their potential functions, GO- and rGO-based scaffolds have particularly attracted attention because of their great clinical projection in tissue regeneration therapies, making them very promising candidates in this field (Table 1). Both GO and rGO have shown a strong impact on the proliferation and differentiation of implemented stem cells when applied on 3D scaffolds in bones, cardiac and neural regenerative medicine, skin and adipose tissues [20]. It has been reported that nano-GO incorporation in nanofibrous scaffolds, made of polycarbonate diol and isosorbide-based polyurethane, enhances the initial adhesion and spreading of myoblasts along with upregulation of myosin heavy chain mRNA levels. The ameliorated regenerative capacity has been ascribed to more suitable mechanical properties (flexibility) conferred to the material by GO enrichment [21]. In another study, autologous platelet-rich plasma (PRP) gels, containing various concentrations of GO, were prepared to promote tendon–bone interface healing and supraspinatus tendon reconstruction in a rabbit model. Again, the incorporation of GO improved the ultrastructure and mechanical properties of the PRP gels [22]. GO also enhances the characteristics of biomaterials used for skin wound dressing and wound healing. The addition of different percentages of GO (from 0 to 2%) on polyurethane material used for protecting skin wounds from external agents, such as microorganisms, and to improve its healing ameliorates its properties. As a matter of fact, polyurethane becomes more biocompatible in the presence of GO, and its antibacterial and mechanical properties appear to increase [23]. In another study, researchers highlighted the compatibility of GO–cellulose nanocomposites in the presence of endothelial cells (ECs) and their capability to improve in vitro EC migration and in vivo rat skin wound healing, thus inducing neo-vascularization and re-epithelization [24]. GO is also an applicable substrate in the presence of mesenchymal stromal cells from adipose tissue. It has been employed for enhancing peripheral nerve regeneration, demonstrating good biocompatibility and protection from the surrounding context, and furthermore improving nerve growth factor and glial-derived neurotrophic factor protein secretion [25].
The next sections will focus on the osteoconductive and chondroconductive properties of GO. Bone reconstruction represents a major challenge and is a global health problem. Enhancements in bone tissue engineering through the design of novel materials and coatings are continuously needed [26]. In parallel, cartilage growth and regeneration require a specific scaffold design that should be strong enough to stabilize the reconstructed cartilage until the newly synthesized ECM attains full mechanical stability and function. Furthermore, scaffold rigidity is important from a functional point of view, particularly in structures that enable nasal breathing, such as the septum, which is responsible for the shape and tension of its surrounding structures [27]. In contrast to the use of graphene in the osteogenesis process, which has been well known for a long time, there is little information available on the chondrogenic process in terms of support and differentiation, although studies on graphene and its derivatives have been increasing in recent years, as reported in the following paragraphs.

3. Osteoconductive Properties of Graphene

Repairing major bone defects by means of bioactive materials, which can induce and support hard tissue formation, is the main goal of bone tissue engineering. Graphene and its derivatives, such as GO, offer outstanding osteoconductive features, making them the optimal choice for bone regeneration [29] (Figure 2B). Graphene and GO are used either alone or in combination with other biomaterials in the form of fillers in composites, coatings for both scaffolds and implants, or vehicles for the delivery of various signaling and therapeutic agents (Figure 3). The presence of graphene derivatives, even in small amounts, can significantly enhance mechanical strength, stiffness, and toughness of the material [30]. Regarding the optimal concentration of GO, there is no specific guideline to follow to obtain an ideal graphene support coating. However, the greatest improvements are usually observed at specific concentrations of graphene loading. Moreover, the presence of the functional groups in GO enables greater interactions with the matrix for more efficient load transfer [31]. In general, the best concentration for cell safety does not exceed 50 µg/mL for pristine graphene and GO and 60 µg/mL for rGO, and it should generally not exceed 1.5% w/v [32].
GO has been used as a reinforcing and osteoconductive agent in a variety of polymeric matrices, such as poly(vinyl alcohol) (PVA) scaffolds fabricated with laser sintering [33]; bioactive glass, which generally suffers from low fracture roughness [34]; cellulose suitable for scaffold production due to its high availability and renewability [35]; acrylic bone cements and titanium specimens, which exhibit lack of bioactivity and susceptibility to infection after implantation [19,36]; and hydroxyapatite-based scaffolds to improve surface roughness [37].
The ability of graphene to promote adherence and proliferation of mesenchymal stem cells (MSCs) and other various cell types, demonstrated for the first time by Kalbacova et al. [38], has been further documented in a plethora of literature. The capability of graphene derivatives to enhance cell features, such as adhesion and growth, resides in their strong proficiency to adsorb proteins, thereby creating a layer between cells and material surfaces. The π-electron cloud of graphene interacts with the inner hydrophobic core of serum proteins to form focal adhesion, an interaction that is even more fortified by GO with its oxygen functional groups [30]. Nayak and colleagues [39] were the first to demonstrate that graphene possesses osteoconductivity in MSCs under osteogenic conditions. From that moment, several studies have focused on this field with the aim of elucidating the molecular mechanisms underlying the osteoinductive properties of graphene and GO. The next section presents an overview of recent studies reporting the osteoconductive properties of GO, also focusing on the advantages of using new differentiation vehicles compared to traditional osteogenic media.

3.1. Enhanced Osteogenesis in the Presence of GO in Novel Differentiation Vehicles

Recent studies have focused on disclosing new potential differentiation strategies that could substitute the traditional ones (Figure 3) [40,41]. Osteogenic conditions are usually established in vitro by supplementing normal culture medium with a mixture of dexamethasone (Dex), ascorbic acid (Asc), and β-glycerophosphate (β-Gly) [42]. One proposed mechanism to explain how GO remarkably enhances osteogenesis is the strong ability of graphene to adsorb osteogenic supplements through noncovalent π–π electron binding, particularly when GO is present. By binding differentiation agents in the medium, GO creates a platform with a pool of concentrated substances, which enables and accelerates osteogenesis. Furthermore, the –OH group in GO has a particular affinity for Asc that is created by hydrogen bonding [43].
Several recent papers have reported the potential of GO in enhancing osteogenesis in traditional osteogenic conditions. Radunovic and coworkers [12] improved the biocompatibility of collagen membranes used for oral surgery of bone defects by coating them with GO. Furthermore, osteogenic differentiation and the anti-inflammatory response of pulp MSCs were enhanced. Many other recent works have reported on suitable osteoconductive characteristics of GO in traditional osteogenic conditions. For example, incorporating GO in a composite bone cement fabricated with polymethyl methacrylate (PMMA) enhanced the osteogenic differentiation of MSCs and progenitor cultures by increasing the number of voids and pores in the developed surface [44]. Kang and colleagues [45] constructed an MSC support made from a sheet of indium tin oxide coated with GO and gold nanoparticles, with the scaffold showing promising MSC osteogenic differentiation efficacy. Li et al. [46] incorporated GO into a methacrylated gelatin scaffold to enhance its properties for bone regeneration. The results showed that GO improved mineralization, and the mineralization was further increased when combined with silica-coated GO due to the enhanced biological activity of the BMP. rGO is also commonly used as a coating. Recently, Kang and coworkers [47] reported that a uniform coating of titanium surfaces with rGO allowed a significant increase of MSC proliferation after only 7 days and promoted the early expression of differentiation markers. The osteoconductive abilities of graphene derivatives have been confirmed not only in in vitro studies but also in vivo. As an example, collagen scaffolds are widely used as biomimetic scaffolds for bone implant [48], and their characteristics can be improved by GO. Zhou and colleagues [49] fabricated a collagen-based scaffold with apatite crystals and increasing concentrations of GO, which improved the coating efficacy. In this study, the authors first demonstrated that GO increased in vitro rat MSC adhesion and proliferation. Then, once implanted into the rat cranial defect, GO-coated scaffolds ameliorated the Ca/phosphate ratio, which was comparable to that of natural bones. In another study, Bahrami et al. [50] used collagen scaffolds (Col) coated with rGO (Col-rGO), showing promising in vitro results based on the capability of the scaffolds to enhance MSC viability and proliferation without cytotoxicity compared to scaffolds without rGO coating. Implantation of Col-rGO into rabbit cranial bone defects confirmed the pro-osteogenic ability of rGO after 12 weeks in vivo, with more bone formation being observed compared to noncoated Col support. In another recent study, GO was combined with poly-lactic-co-glycolic acid (PLGA), L-lysine, and gold nanoparticles. When implanted into rabbit radial defects, a synergistic effect was observed, with a high bone amount and mineralized collagen deposition [51].
In recent years, the possibility of investigating GO-dependent enhancement of osteogenic differentiation in novel osteogenic conditions has started to be a focus. As an example, based on the rationale that chondrocytes release substances that improve osteogenic differentiation during endochondral ossification, Kim et al. [52] compared MSC differentiation potential in traditional osteogenic differentiation medium and chondrocyte-conditioned medium in the presence of GO substrates. The results showed that GO substrates increased cell surface area and enhanced cell adhesion and osteogenic differentiation. Priming of cells with chondrocyte-conditioned medium could further induce synergistic osteogenesis on GO substrates. Another approach to promote skeletal tissue regeneration could be to enhance the release of ions, such as Ca2+, PO42−, Li+, and Mg+ (the so-called inducerons), capable of starting stem cell differentiation from the surface of graphene derivatives [53]. In a recent work, it was reported that phosphate–GO-functionalized resorbable scaffolds used for bone regeneration were able to release inducerons in aqueous solutions, including Ca2+ and PO43−. Calcium phosphate graphene could intrinsically induce osteogenesis in vitro and trigger ectopic bone formation in vivo in the presence of bone marrow stromal cells (BMSCs), thereby revealing phosphate–GO-functionalized materials as intrinsically inductive scaffolds capable of revolutionizing bone regeneration [54].
Given the widely demonstrated ability of GO to speed up the osteogenic process in both traditional and nontraditional conditions, the next section focuses on the most important MSC adhesion molecular pathways affected by graphene.

3.2. Stimulation of FAK-Related Pathways by GO Induces MSC Adherence and Osteogenic Differentiation

Several molecular studies on graphene-related osteoinductive capability have focused their attention on different pathways triggered in MSCs to enhance differentiation, such as phosphoinositide 3-kinases (PI3K)/protein kinase B (Akt)/glycogen synthase kinase (GSK)-3β/β-catenin [55], α5β1 and αvβ3 integrin [56], and reorganization of actin microfilaments [57]. As mentioned earlier, the π-electron cloud of graphene interacts with the inner hydrophobic core of serum proteins to form focal adhesions (FAs), an interaction that is even more enhanced by the oxygen group of GO [30]. FAs are specialized sites within the cell where clustered integrin receptors interact with the extracellular matrix (ECM) on the outside of cells and with the actin cytoskeleton on the inside, thus acting as transducers of mechanic stimuli, a process known as mechanotransduction [58]. It is broadly known that mechanical forces play a significant role in regulating the fate of MSCs, and it has been shown that controlling mechanical stimuli can in turn control MSC lineage specification [59], mainly in the presence of materials used as bone grafts [60]. It has been demonstrated that, in the presence of GO-enriched materials, such as polyethylene glycol (PEG)-based cryogel scaffolds, improved cell attachment and biocompatibility are mediated by FAK signaling activation [61]. Xie et al. [62] demonstrated that MSCs seeded onto graphene-coated polydimethylsiloxane (PDMS) substrates possess higher expression of integrin/FAK proteins and osteogenic markers compared to MSCs seeded onto PDMS alone (Figure 3). Again, FAK/p38 signaling pathways were proven to be involved in the enhanced osteogenic differentiation of MSCs in vitro, along with upregulated expression of focal adhesion (vinculin) on the GO-coated surface [63]. In another work, it was reported that MSC osteogenic differentiation induced by nano-GO modification on a titanium implant surface was driven by FAK/p38 signaling pathways, thus confirming that GO coating induced accelerated osteointegration and osteogenesis in vivo [63].

3.3. GO in Dentistry

GO has also aroused interest in the field of odontogenesis and regenerative dentistry (Table 1), as demonstrated by the plethora of works reporting the exceptional properties of graphene in this field [64].
Di Carlo and coresearchers [65] established a good and practical protocol to covalently coat cortical membranes commonly used in oral surgical dentistry with GO and analyzed the ability of this new material to promote adhesion, growth, and osteogenic differentiation of dental pulp stem cells (DPSCs) compared to membranes without coating. SEM analysis revealed that DPSCs formed a monolayer on discs, were contiguous to each other, and released granules of inorganic matrix, which was confirmed by alizarin red staining. Additionally, the cytotoxicity recorded in DPSCs grown on GO-coated discs was strongly reduced compared to cytotoxicity of DPSCs grown on titanium without GO. Moreover, GO augments the roughness of scaffold, and this characteristic improves cell attachment, proliferation, and differentiation. In another study, the same group [66] tested the ability of DPSCs to grow, proliferate, and differentiate onto GO foils in osteogenic conditions. The results showed that GO foils exhibited good biocompatibility and led to increased cell viability compared to polystyrene, which was used as a control. Furthermore, the authors reported that the cytotoxicity of GO foils was similar or lower compared to polystyrene, and earlier osteogenic differentiation was also enhanced with GO foils. Finally, the results showed the good chemical stability of GO sheets in aqueous solution for 7 days.
Even though graphene-mediated MSC adhesion properties are essential for osteogenesis and odontogenesis, another crucial aspect to investigate is the immunomodulatory properties of graphene-based materials, which will be discussed in the next section.

4. Immunomodulatory Properties of GO in Osteogenic Conditions

The term osteoimmunology refers to the existing link between the immune and the skeletal systems. Both immune cells and cytokines contribute to the regulation of bone homeostasis, and bone cells also influence immune cell functions. Therefore, the immune microenvironment is crucial in determining the speed and outcome of bone healing, repair, and regeneration [67]. In the presence of a bone graft, an immune response is triggered independent of the material used, along with migration of immune cells in the affected area [68]. Currently, there are few studies on the influence of graphene on cells belonging to the immune system. The effects of GO coatings on immunoregulation and the subsequent impacts on osteogenesis are poorly understood. It has been shown that activated monocytes can communicate pro-osteogenic signals to MSCs, promoting osteogenesis [69]. Thus, nanomaterials specifically designed to provoke immune-mediated bone formation are still missing. It has been reported that conjugating the intrinsic immune characteristics of GO with the well-recognized osteoinductive capacity of calcium phosphate (CaP) in a biocompatible nanomaterial, namely maGO–CaP (monocytes activator GO complexed with CaP), may be a promising strategy to stimulate bone formation ex vivo and in vivo [70]. In another work, Su and coworkers [71] focused their attention on the effect of graphene on local immunity stimulation, particularly on the activity of macrophages, which are essential for osteoimmunology as they switch between the proinflammatory M1 phenotype or the anti-inflammatory M2 phenotype. GO-coated titanium (Ti–GO) surfaces exhibited good biocompatibility with the ability to stimulate the expression of osteogenic genes and ECM mineralization in human MSCs. Interestingly, macrophages seeded on Ti–GO showed proinflammatory activation under physiological conditions. SEM analysis revealed an M1 morphology, and a mild inflammation was also demonstrated by increased levels of proinflammatory interleukin (IL)-6, tumor necrosis factor-α (TNF-α), and IL-1β. When MSCs were seeded on Ti–GO in an environment mimicking acute inflammatory conditions, Ti–GO attenuated inflammatory responses, as shown by the downregulation of proinflammatory cytokines. Moreover, conditioned medium collected from macrophages stimulated by Ti–GO played a significant stimulatory role in hMSC osteogenic differentiation. This study confirms the strong potential of GO in immunomodulatory processes, even though further investigation about its influence on the immunity system is necessary.
Another main issue that can induce immunity system activation and lead to implant failure in the presence of bone grafts is the potential release of small debris from scaffolds used in standard orthopedic procedures. Chang and co-researchers [72] analyzed the osteolysis potential of graphene and preparation of GO particles in vitro in the presence of murine macrophages and in a murine model of calvaria. The results showed that GO induced an in vitro proinflammatory reaction characterized by increasing concentration of IL-6 and TNF-α released. However, the in vitro results were not confirmed in vivo. The authors speculated that the inflammatory reaction was a first step for inducing bone formation through activation of macrophages by graphene or GO, as previously described. As a matter of fact, macrophages switch from the proinflammatory M1 phenotype to the anti-inflammatory M2 phenotype in 72 h, thus promoting osteogenesis (Figure 4). Even though the available studies on the involvement of the immunity system in response to GO are promising, more in-depth research in this field is required.

5. Chondroinductive Properties of Graphene

Cartilage damaged by trauma has a limited capacity to heal. Thus, the regeneration of articular cartilage remains a major challenge in orthopedics and tissue engineering. Currently, treatment of small articular cartilage injuries involves administration of nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, corticosteroid, and hyaluronic acid (HA) injections, viscosupplementation, articular chondroplasty, and artificial joint replacement [73]. Larger defects are managed with osteochondral allograft or total joint arthroplasty. However, the future of managing cartilage defects lies in providing medication-free therapeutic solutions through cartilage regeneration using tissue-engineered cartilage [74]. The following paragraphs summarize the most recent works related to graphene and its derivatives, in particular GO, employed in chondrogenesis induction and cartilage regeneration (Table 1).

5.1. Graphene as a Substitute for Chondrogenic Differentiation Factors

As previously reported for osteogenesis, graphene is a good nanocarrier for several molecules. To induce and improve MSC osteogenesis, researchers typically use a medium supplemented with differentiation or growth factors. Graphene, due to its structure and ability, can soak up molecules dissolved in the medium and improve their entrance into the cells, thereby speeding up the process. The same approach can be applied to induce chondrogenesis in MSCs (Figure 5). With this aim, MSCs can be cultured in the presence of GO derivatives in chondrogenic conditions in the presence of dexamethasone, ascorbate-2-phosphate, sodium pyruvate, and transforming growth factor-beta 1 (TGF-β1) [75]. However, the feasibility of using GO directly as a chondroinductive factor without a differentiation medium has also been investigated. In a recent study, the effect of graphene alone without employing exogenous differentiation factors was explored for the first time [76]. In this study, MSCs were directly cultured in the presence of three different concentrations of GO nanosheets into a photopolymerizable poly(D,L-lactic acid)/polyethylene glycol hydrogel (PDLLA hydrogel). The incorporation of GO into hydrogel did not affect cell viability at all as the GO concentration and chondrogenic markers appeared to be upregulated compared to hydrogels without GO. ECM deposition was also not affected. This study marked the starting point for further evaluations of GO as a chondroinductive material without differentiation medium.
As mentioned earlier, TGF-β1 and TGF-β3 are two of the major chondrogenic differentiation factors and are frequently used alone or in combination with other differentiation molecules in the chondrogenic differentiation medium. During the development of growth plates, BMP signaling promotes the maturation of chondrocytes to facilitate ossification, whereas TGF-beta signaling inhibits hypertrophic differentiation to preserve adequate chondrocytes within the growth plate. Both TGF-beta signaling and BMP signaling are indispensable for the maintenance and repair of articular cartilage [77]. At a molecular level, TGF-β1 improves MSC proliferation and the production of ECM components, thus inducing downregulation of collagen type I expression and upregulation of collagen type II and aggrecan (ACAN) expression. In parallel, TGF-β3 increases production of the ECM components, mainly sulphated glycosaminoglycans (GAG). Their activities are carried out through the Smad pathway, inducing a phosphorylation of Smad that translocates into the MSC nucleus and triggers gene transcription, inducing chondrogenic cell commitment and differentiation [78]. Interestingly, it has been shown that TGF-β activity, particularly of TGF-β3, can induce side-effects, including inflammation, fibroplasia, and a hypertrophic phenotype of mesenchymal stem cells, during chondrogenesis in a time- and concentration-dependent manner [79]. Based on TGF-β’s hypertrophic potential in chondrogenesis, researchers have attempted to induce chondrogenic differentiation using differentiation medium without TGF-β and to improve differentiation using materials such as GO, which can enhance transport and entry of other molecules present in the differentiation medium. A recent study [80] evaluated the ability of poly-Ɛ-caprolactone (PCL) scaffold combined with different concentrations of pristine graphene nanopowders (1%, 3%, 5%, and 10%) to induce chondrogenic MSC differentiation in the presence of TGF-β-free differentiation medium. In vitro cell tests indicated that the prepared grid-like graphene/PCL composite scaffolds possessed good cytocompatibility and nontoxicity for mouse bone marrow MSCs. Stem cells showed good adhesion and proliferation on scaffolds, and they also disclosed a chondrogenic differentiation in the absence of transforming growth factors. In another study, GO was incorporated into alginate-based hydrogels developed for 3D-printed scaffold fabrication. The hydrogel was based on a photocrosslinkable alginate bioconjugated with both gelatin and chondroitin sulfate to mimic the cartilage extracellular matrix, while the nanofiller was based on GO to enhance printability and cell proliferation. The results showed that the incorporation of GO into the hydrogel inks considerably improved the shape fidelity and resolution of 3D-printed scaffolds because of a faster viscosity recovery post extrusion. In vitro assays on human adipose tissue-derived mesenchymal stem cells (hADMSCs) showed that bioconjugated scaffolds presented higher cell proliferation than pure alginate, had good biocompatibility, and induced chondrogenic differentiation without exogenous pro-chondrogenic factors [81].
Even though the extraordinary properties of graphene, in particular GO, can induce chondrogenic differentiation and regeneration without the addition of differentiation factors, graphene can also be used as a nanocarrier for differentiation factors.

5.2. Graphene as a Nanocarrier for Natural and Synthetized Chondrogenic Differentiation Factors

Differentiation/growth factors (of natural origin or synthesized) can be administered in situ to obtain rapid repair of local cartilage lesions. However, there are frequent issues to overcome, such as inactivation of these molecules in the site of action or the inability to retain factors at a local level. To overcome these limitations, a possible strategy could be to use carrier materials that are able to release these factors in the interested region. Nevertheless, this approach presents frequent problems, such as the large amount of early release of growth factors from these materials followed by little long-term release [82], which potentially induces side effects, such as TGF-β-related hypertrophic condition. A suitable approach to limit these side-effects is to use a second delivery system that can release growth factors in a controlled manner [83]. With this aim, the use of graphene as a nanocarrier and the use of GO could be a feasible delivery strategy. In a 2014 study [84], GO was used as a nanocarrier to improve controlled TGF-β diffusion into MSCs. Recently, Zhou and coworkers [85] designed a delivery system formed by GO flakes where TGF-β3 was adsorbed and embedded in collagen hydrogels encapsulating MSCs. The effects of this complex compared to exogenously delivered TGF-β3 in culture medium were evaluated with the aim of investigating the capability of GO to adsorb and release active molecules, such as TGF-β3. It was found that GO adsorbed approximately 99% of TGF-β3 molecules and released < 1.7%. Moreover, the gene expression of Sry-type HMG box (SOX9), collagen type II, and ACAN indicated better chondrogenic differentiation of MSCs. Moreover, phosphorylation of Smad2 occurred when TGF-β3 was combined with GO, whereas phosphorylation was strongly reduced in samples with TGF-β3 or GO alone (Figure 5).
Similarly, rGO can be used as a nanocarrier for specific molecules to improve chondrogenic differentiation. Jiao and coworkers [86] investigated the ability of rGO in combination with gelatin to form a scaffold (rGO–Ge) able to deliver kartogenin (KGN). KGN is a new heterocyclic compound showing high chondrogenic potential [87]. The rGO–Ge + KGN combination promoted MSC chondrogenic differentiation in a synergistic manner. Immunofluorescence and PCR analysis of SOX9, collagen type II, collagen type X, and GAG demonstrated the good pro-chondrogenic effect of this combination.
These findings suggest GO has good potential in the release of specific molecules, thus improving chondrogenic differentiation, although further investigations are needed to support this hypothesis. In addition, functionalization of the graphene surface with active molecules to enhance the chondrogenic capability of graphene is a new and challenging strategy.
Table 1. Biomedical applications of GO. The table summarizes in vitro and in vivo studies related to GO and rGO.
Table 1. Biomedical applications of GO. The table summarizes in vitro and in vivo studies related to GO and rGO.
Graphene FormulationBiomedical Applications
De Marco, P. et al. [11]Collagen membranes enriched with GOImplementation of bone deposition In vitro
Radunovic, M. et al. [12]Collagen membranes enriched with GOImplementation of bone formation and improvement of the clinical performance of collagen membranesIn vitro
Zarafu, I. et al. [16]Amines-functionalized GOAntimicrobial and antibiofilm activityIn vitro
Deng, X. et al. [17]GO combined with polyethylene glycol (PEG)Prevention of osteosarcoma invasion In vitro and in vivo
Di Carlo, R. et al. [19]GO-coated titanium surfacesImprovement of properties related to dental implantation materialsIn vitro
Jo, S.B. et al. [21]Polyurethane–nanoGO fibersPotential matrix for skeletal muscle engineeringIn vitro
Bao, D. et al. [22]Platelet-rich plasma gels with GO (PRP/GO)Tendon–bone interface healing/supraspinatus tendon reconstructionIn vitro and in vivo
Sadeghianmaryan, A. et al. [23]Electrospinning polyurethane–GOWound dressingIn vitro
Soliman, M. et al. [24]GO–cellulose nanocompositeWound healingIn vitro and in vivo
Llewellyn, S.H. et al. [25]GO substratesPeripheral nerve regenerationIn vitro
Dinescu, S. et al. [29]GO–Chitosan-based 3D scaffoldsBone tissue engineeringIn vitro and in vivo
Son, S.A. et al. [34]Mesoporous bioactive glass combined with GO quantum dotsDentin hypersensitivityIn vitro
Yilmaz, E. et al. [37]HA/GO/COL bioactive composite coating on Ti16NbAntibacterial activity,improvement of cell adhesion and viabilityIn vitro
Kalbacova, M. et al. [38]Single graphene layerImprovement of osteoconductivityIn vitro
Nayak, T.R. et al. [39]Graphene sheetsAcceleration of cell differentiationIn vitro
Arumugam, N. et al. [43]GO quantum dotsDetection of ascorbic acidIn vitro
Krukiewicz, K. et al. [44]GO–poly(methyl methacrylate)Bone tissue engineeringIn vitro
Kang, M.S. et al. [45]rGO–titanium substratesDental and orthopaedic bone substitutesIn vitro
Li, Z. et al. [46]Methacrylated gelatin–GOBone tissue engineeringIn vitro and in vivo
Kang, E.S. et al. [47]Gold nanostructure/peptide-nanopatterned GOTreatment of disorders of bone tissueIn vitro
Zhou, C. et al. [49]Collagen-functionalized GOEnhancement of biomimetic mineralizationIn vitro and in vivo
Bahrami, S.et al. [50]rGO-coated collagen scaffoldsBone tissue engineeringIn vitro and in vivo
Fu, C. et al. [51]L-lysine-functionalized GO nanoparticles on PLGAImprovement of osseointegration of bone implantsIn vitro and in vivo
Kim, J. et al. [52]Glass slides coated with GOUpregulation of osteogenic responsesIn vitro
Arnold, A.M. et al. [54]Phosphate–GO releasing inducerons (Ca2+ and PO43−)Bone regenerationIn vitro and in vivo
Newby, S.D. et al. [56]Functionalized graphene nanoparticlesInduction of specific ECM protein expression, bone repair, and regenerationIn vitro
Kim, H.D. et al. [61]GO incorporated into cryogel-based scaffoldImprovement of osteogenic commitmentIn vitro
Di Carlo, R. et al. [65]GO-decorated cortical membraneBone regenerationIn vitro
Di Crescenzo, A. et al. [66]GO foilsBone regenerationIn vitro
Bordoni, V. et al. [70]Monocytes activator GO complexed with calcium phosphate (maGO–CaP)Immunomodulatory effects in osteogenesisIn vitro and in vivo
Su, J. et al. [71]GO-coated titaniumImmunomodulatory effects in osteogenesisIn vitro
Chang, T.K. et al. [72]Graphene and GO particlesApplication in orthopaedic prosthesesIn vitro and in vivo
Shen, H. et al. [76]GO-incorporated hydrogelBiologics-free approach for cartilage tissue engineeringIn vitro
Deliormanlı, A.M. et al. [80]Grid-like graphene/PCL composite scaffoldsChondrogenic differentiationIn vitro
Olate-Moya, F. et al. [81]Alginate-based hydrogel with GOChondroinductive capabilityIn vitro
Yoon H.H., et al. [84]GO sheetsChondroinductive capabilityIn vitro
Zhou, M. et al. [85]Adsorbed TGF-β3 to GO flakes incorporated into collagen hydrogelDelivering of growth factors and chondrogenic differentiation inductionIn vitro
Jiao, D. et al. [83]Biodegradable gelatin–rGOPromoting chondrogenic differentiation through kartogenin deliveryIn vitro

6. Conclusions

Graphene, and in particular its derivative GO, has triggered enormous interest in the scientific and industrial communities owing to its simple synthesis and versatility. Indeed, the graphene chemistry offers a plethora of opportunities for the design of multifunctional nanocomposites and devices with promising uses in tissue engineering. Among its several biomedical applications, GO has been particularly used for bone regeneration purposes as it has been shown to be capable of enhancing and ameliorating osteoconductive properties of materials in vitro and in vivo. Recently, properties of GO have also been successfully applied in the field of cartilage regeneration, achieving promising results in vitro. Very interestingly, graphene-based materials are emerging as attractive materials that are able to modulate inflammatory pathways in immune cells, thus promoting and accelerating tissue regeneration after implantation.

Author Contributions

Conceptualization, S.Z. and M.G.; methodology, A.R.; funding, A.C., S.Z., and M.G.; writing—original draft preparation, A.R. and M.G.; writing—review and editing, A.C., S.Z. and M.G.; supervision, M.G. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the Italian Ministry of University attributed to Prof. Amelia Cataldi, Prof. Susi Zara, and Marialucia Gallorini (Fondi FAR 2020).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data sharing is not applicable for this paper.

Acknowledgments

Programma Operativo Nazionale (PON) Ricerca e Innovazione 2014–2020 Fondo Sociale Europeo, Azione I.2 “Attrazione e Mobilità Internazionale dei Ricercatori” (Marialucia Gallorini).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Huang, X.; Yin, Z.; Wu, S.; Qi, X.; He, Q.; Zhang, Q.; Yan, Q.; Boey, F.; Zhang, H. Graphene-based materials: Synthesis, characterization, properties, and applications. Small 2011, 7, 1876–1902. [Google Scholar] [CrossRef] [PubMed]
  2. Castro-Neto, A.H.; Guinea, F.; Peres, N.M.R.; Novoselov, K.S.; Geim, A.K. The electronic properties of graphene. Rev. Mod. Phys. 2009, 81, 109. [Google Scholar] [CrossRef]
  3. Wallace, P.R. The Band Theory of Graphite. Phys. Rev. 1947, 71, 622–634. [Google Scholar] [CrossRef]
  4. Choi, W.; Lahiri, I.; Seelaboyina, R.; Kang, Y.S. Synthesis of Graphene and Its Applications: A Review. Crit. Rev. Solid State Mat. Sci. 2018, 35, 52–71. [Google Scholar] [CrossRef]
  5. Wang, X.Y.; Richter, M.; He, Y.; Björk, J.; Riss, A.; Rajesh, R.; Garnica, M.; Hennersdorf, F.; Weigand, J.J.; Narita, A.; et al. Exploration of pyrazine-embedded antiaromatic polycyclic hydrocarbons generated by solution and on-surface azomethine ylide homocoupling. Nat. Commun. 2017, 8, 1948. [Google Scholar] [CrossRef]
  6. Liao, C.; Li, Y.; Tjong, S.C. Graphene Nanomaterials: Synthesis, Biocompatibility, and Cytotoxicity. Int. J. Mol. Sci. 2018, 19, 3564. [Google Scholar] [CrossRef]
  7. Sekiya, R.; Haino, T. Edge-Functionalized Nanographenes. Chemistry. 2021, 27, 187–199. [Google Scholar] [CrossRef]
  8. Dideikin, A.T.; Vul’, A.Y. Graphene Oxide and Derivatives: The Place in Graphene Family. Front. Phys. 2019, 6, 149. [Google Scholar] [CrossRef]
  9. Banerjee, A.N. Graphene and its derivatives as biomedical materials: Future prospects and challenges. Interface Focus. 2018, 8, 20170056. [Google Scholar] [CrossRef]
  10. Durán, N.; Martinez, D.S.; Silveira, C.P.; Durán, M.; de Moraes, A.C.; Simões, M.B.; Alves, O.L.; Fávaro, W.J. Graphene oxide: A carrier for pharmaceuticals and a scaffold for cell interactions. Curr. Top Med. Chem. 2015, 15, 309–327. [Google Scholar] [CrossRef]
  11. De Marco, P.; Zara, S.; De Colli, M.; Radunovic, M.; Lazović, V.; Ettorre, V.; Di Crescenzo, A.; Piattelli, A.; Cataldi, A.; Fontana, A. Graphene oxide improves the biocompatibility of collagen membranes in an in vitro model of human primary gingival fibroblasts. Biomed. Mater. 2017, 12, 055005. [Google Scholar] [CrossRef]
  12. Radunovic, M.; De Colli, M.; De Marco, P.; Di Nisio, C.; Fontana, A.; Piattelli, A.; Cataldi, A.; Zara, S. Graphene oxide enrichment of collagen membranes improves DPSCs differentiation and controls inflammation occurrence. J. Biomed. Mater. Res. A 2017, 105, 2312–2320. [Google Scholar] [CrossRef] [PubMed]
  13. Geim, A.K. Graphene: Status and prospects. Science 2009, 324, 1530–1534. [Google Scholar] [CrossRef] [PubMed]
  14. Gaur, M.; Misra, C.; Yadav, A.B.; Swaroop, S.; Maolmhuaidh, F.Ó.; Bechelany, M.; Barhoum, A. Biomedical Applications of Carbon Nanomaterials: Fullerenes, Quantum Dots, Nanotubes, Nanofibers, and Graphene. Materials 2021, 14, 5978. [Google Scholar] [CrossRef]
  15. Yim, Y.; Shin, H.; Ahn, S.M.; Min, D.H. Graphene oxide-based fluorescent biosensors and their biomedical applications in diagnosis and drug discovery. Chem. Commun. 2021, 57, 9820–9833. [Google Scholar] [CrossRef] [PubMed]
  16. Zarafu, I.; Turcu, I.; Culiță, D.C.; Petrescu, S.; Popa, M.; Chifiriuc, M.C.; Limban, C.; Telehoiu, A.; Ioniță, P. Antimicrobial Features of Organic Functionalized Graphene-Oxide with Selected Amines. Materials 2018, 11, 1704. [Google Scholar] [CrossRef] [PubMed]
  17. Deng, X.; Liang, H.; Yang, W.; Shao, Z. Polarization and function of tumor-associated macrophages mediate graphene oxide-induced photothermal cancer therapy. J. Photochem. Photobiol. B 2020, 208, 111913. [Google Scholar] [CrossRef]
  18. Daniyal, M.; Liu, B.; Wang, W. Comprehensive Review on Graphene Oxide for Use in Drug Delivery System. Curr. Med. Chem. 2020, 27, 3665–3685. [Google Scholar] [CrossRef]
  19. Di Carlo, R.; Di Crescenzo, A.; Pilato, S.; Ventrella, A.; Piattelli, A.; Recinella, L.; Chiavaroli, A.; Giordani, S.; Baldrighi, M.; Camisasca, A.; et al. Osteoblastic Differentiation on Graphene Oxide-Functionalized Titanium Surfaces: An In Vitro Study. Nanomaterials 2020, 10, 654. [Google Scholar] [CrossRef]
  20. Maleki, M.; Zarezadeh, R.; Nouri, M.; Sadigh, A.R.; Pouremamali, F.; Asemi, Z.; Kafil, H.S.; Alemi, F.; Yousefi, B. Graphene Oxide: A Promising Material for Regenerative Medicine and Tissue Engineering. Biomol. Concepts 2020, 11, 182–200. [Google Scholar] [CrossRef]
  21. Jo, S.B.; Erdenebileg, U.; Dashnyam, K.; Jin, G.Z.; Cha, J.R.; El-Fiqi, A.; Knowles, J.C.; Patel, K.D.; Lee, H.H.; Lee, J.H.; et al. Nano-graphene oxide/polyurethane nanofibers: Mechanically flexible and myogenic stimulating matrix for skeletal tissue engineering. J. Tissue Eng. 2020, 11, 2041731419900424. [Google Scholar] [CrossRef] [PubMed]
  22. Bao, D.; Sun, J.; Gong, M.; Shi, J.; Qin, B.; Deng, K.; Liu, G.; Zeng, S.; Xiang, Z.; Fu, S. Combination of graphene oxide and platelet-rich plasma improves tendon-bone healing in a rabbit model of supraspinatus tendon reconstruction. Regen. Biomater. 2021, 8, 45. [Google Scholar] [CrossRef] [PubMed]
  23. Sadeghianmaryan, A.; Sardroud, H.A.; Allafasghari, S.; Yazdanpanah, Z.; Naghieh, S.; Gorji, M.; Chen, X. Electrospinning of polyurethane/graphene oxide for skin wound dressing and its in vitro characterization. J. Biomater. Appl. 2020, 35, 135–145. [Google Scholar] [CrossRef]
  24. Soliman, M.; Sadek, A.A.; Abdelhamid, H.N.; Hussein, K. Graphene oxide-cellulose nanocomposite accelerates skin wound healing. Res. Vet. Sci. 2021, 137, 262–273. [Google Scholar] [CrossRef] [PubMed]
  25. Llewellyn, S.H.; Faroni, A.; Iliut, M.; Bartlam, C.; Vijayaraghavan, A.; Reid, A.J. Graphene Oxide Substrate Promotes Neurotrophic Factor Secretion and Survival of Human Schwann-Like Adipose Mesenchymal Stromal Cells. Adv. Biol. 2021, 5, e2000271. [Google Scholar] [CrossRef] [PubMed]
  26. Soleymani Eil Bakhtiari, S.; Bakhsheshi-Rad, H.R.; Karbasi, S.; Tavakoli, M.; Razzaghi, M.; Ismail, A.F.; RamaKrishna, S.; Berto, F. Polymethyl Methacrylate-Based Bone Cements Containing Carbon Nanotubes and Graphene Oxide: An Overview of Physical, Mechanical, and Biological Properties. Polymers 2020, 12, 1469. [Google Scholar] [CrossRef]
  27. Cheng, A.; Schwartz, Z.; Kahn, A.; Li, X.; Shao, Z.; Sun, M.; Ao, Y.; Boyan, B.D.; Chen, H. Advances in Porous Scaffold Design for Bone and Cartilage Tissue Engineering and Regeneration. Tissue Eng. Part B Rev. 2019, 25, 14–29. [Google Scholar] [CrossRef]
  28. Blanco, F.J.; Ruiz-Romero, C. New targets for disease modifying osteoarthritis drugs: Chondrogenesis and Runx1. Ann. Rheum. Dis. 2013, 72, 631–634. [Google Scholar] [CrossRef]
  29. Dinescu, S.; Ionita, M.; Ignat, S.R.; Costache, M.; Hermenean, A. Graphene Oxide Enhances Chitosan-Based 3D Scaffold Properties for Bone Tissue Engineering. Int. J. Mol. Sci. 2019, 20, 5077. [Google Scholar] [CrossRef]
  30. Daneshmandi, L.; Barajaa, M.; Tahmasbi Rad, A.; Sydlik, S.A.; Laurencin, C.T. Graphene-Based Biomaterials for Bone Regenerative Engineering: A Comprehensive Review of the Field and Considerations Regarding Biocompatibility and Biodegradation. Adv. Healthc. Mater. 2021, 2001414. [Google Scholar] [CrossRef]
  31. Papageorgiou, D.G.; Li, Z.; Liu, M.; Kinloch, I.A.; Young, R.J. Mechanisms of mechanical reinforcement by graphene and carbon nanotubes in polymer nanocomposites. Nanoscale 2020, 12, 2228–2267. [Google Scholar] [CrossRef] [PubMed]
  32. Mohammadrezaei, D.; Golzar, H.; Rezai Rad, M.; Omidi, M.; Rashedi, H.; Yazdian, F.; Khojasteh, A.; Tayebi, L. In vitro effect of graphene structures as an osteoinductive factor in bone tissue engineering: A systematic review. J. Biomed. Mater. Res. A 2018, 106, 2284–2343. [Google Scholar] [CrossRef] [PubMed]
  33. Aslam Khan, M.U.; Haider, A.; Abd Razak, S.I.; Abdul Kadir, M.R.; Haider, S.; Shah, S.A.; Hasan, A.; Khan, R.; Khan, S.D.; Shakir, I. Arabinoxylan/graphene-oxide/nHAp-NPs/PVA bionano composite scaffolds for fractured bone healing. J. Tissue Eng. Regen. Med. 2021, 15, 322–335. [Google Scholar] [CrossRef] [PubMed]
  34. Son, S.A.; Kim, D.H.; Yoo, K.H.; Yoon, S.Y.; Kim, Y.I. Mesoporous Bioactive Glass Combined with Graphene Oxide Quantum Dot as a New Material for a New Treatment Option for Dentin Hypersensitivity. Nanomaterials 2020, 10, 621. [Google Scholar] [CrossRef]
  35. Oprea, M.; Voicu, S.I. Cellulose Composites with Graphene for Tissue Engineering Applications. Materials 2020, 13, 5347. [Google Scholar] [CrossRef]
  36. Zapata, M.E.V.; Tovar, C.D.G.; Hernandez, J.H.M. The Role of Chitosan and Graphene Oxide in Bioactive and Antibacterial Properties of Acrylic Bone Cements. Biomolecules 2020, 10, 1616. [Google Scholar] [CrossRef]
  37. Yılmaz, E.; Çakıroğlu, B.; Gökçe, A.; Findik, F.; Gulsoy, H.O.; Gulsoy, N.; Mutlu, Ö.; Özacar, M. Novel hydroxyapatite/graphene oxide/collagen bioactive composite coating on Ti16Nb alloys by electrodeposition. Mater. Sci. Eng. C Mater. Biol. Appl. 2019, 101, 292–305. [Google Scholar] [CrossRef]
  38. Kalbacova, M.; Broza, A.; Kong, J.; Kalbac, M. Graphene substrates promote adherence of human osteoblasts and mesenchymal stromal cells. Carbon 2010, 48, 4323–4329. [Google Scholar] [CrossRef]
  39. Nayak, T.R.; Andersen, H.; Makam, V.S.; Khaw, C.; Bae, S.; Xu, X.; Ee, P.L.; Ahn, J.H.; Hong, B.H.; Pastorin, G.; et al. Graphene for controlled and accelerated osteogenic differentiation of human mesenchymal stem cells. ACS Nano 2011, 5, 4670–4678. [Google Scholar] [CrossRef]
  40. Gallorini, M.; Di Carlo, R.; Pilato, S.; Ricci, A.; Schweikl, H.; Cataldi, A.; Fontana, A.; Zara, S. Liposomes embedded with differentiating factors as a new strategy for enhancing DPSC osteogenic commitment. Eur. Cell Mater. 2021, 41, 108–120. [Google Scholar] [CrossRef]
  41. Paduano, F.; Aiello, E.; Cooper, P.R.; Marrelli, B.; Makeeva, I.; Islam, M.; Spagnuolo, G.; Maged, D.; De Vito, D.; Tatullo, M. A Dedifferentiation Strategy to Enhance the Osteogenic Potential of Dental Derived Stem Cells. Front. Cell Dev. Biol. 2021, 9, 668558. [Google Scholar] [CrossRef] [PubMed]
  42. Langenbach, F.; Handschel, J. Effects of dexamethasone, ascorbic acid and β-glycerophosphate on the osteogenic differentiation of stem cells in vitro. Stem Cell Res. Ther. 2013, 4, 117. [Google Scholar] [CrossRef] [PubMed]
  43. Arumugam, N.; Kim, J. Quantum dots attached to graphene oxide for sensitive detection of ascorbic acid in aqueous solutions. Mater. Sci. Eng. C Mater. Biol. Appl. 2018, 92, 720–725. [Google Scholar] [CrossRef]
  44. Krukiewicz, K.; Putzer, D.; Stuendl, N.; Lohberger, B.; Awaja, F. Enhanced Osteogenic Differentiation of Human Primary Mesenchymal Stem and Progenitor Cultures on Graphene Oxide/Poly(methyl methacrylate) Composite Scaffolds. Materials 2020, 13, 2991. [Google Scholar] [CrossRef] [PubMed]
  45. Kang, M.S.; Jeong, S.J.; Lee, S.H.; Kim, B.; Hong, S.W.; Lee, J.H.; Han, D.W. Reduced graphene oxide coating enhances osteogenic differentiation of human mesenchymal stem cells on Ti surfaces. Biomater. Res. 2021, 25, 4. [Google Scholar] [CrossRef] [PubMed]
  46. Li, Z.; Xiang, S.; Lin, Z.; Li, E.N.; Yagi, H.; Cao, G.; Yocum, L.; Li, L.; Hao, T.; Bruce, K.K.; et al. Graphene oxide-functionalized nanocomposites promote osteogenesis of human mesenchymal stem cells via enhancement of BMP-SMAD1/5 signaling pathway. Biomaterials 2021, 277, 121082. [Google Scholar] [CrossRef]
  47. Kang, E.S.; Kim, H.; Han, Y.; Cho, Y.W.; Son, H.; Luo, Z.; Kim, T.H. Enhancing osteogenesis of adipose-derived mesenchymal stem cells using gold nanostructure/peptide-nanopatterned graphene oxide. Colloids Surf. B Biointerfaces 2021, 204, 111807. [Google Scholar] [CrossRef]
  48. Preethi Soundarya, S.; Haritha Menon, A.; Viji Chandran, S.; Selvamurugan, N. Bone tissue engineering: Scaffold preparation using chitosan and other biomaterials with different design and fabrication techniques. Int. J. Biol. Macromol. 2018, 119, 1228–1239. [Google Scholar] [CrossRef]
  49. Zhou, C.; Liu, S.; Li, J.; Guo, K.; Yuan, Q.; Zhong, A.; Yang, J.; Wang, J.; Sun, J.; Wang, Z. Collagen Functionalized with Graphene Oxide Enhanced Biomimetic Mineralization and in Situ Bone Defect Repair. ACS Appl. Mater. Interfaces 2018, 10, 44080–44091. [Google Scholar] [CrossRef]
  50. Bahrami, S.; Baheiraei, N.; Shahrezaee, M. Biomimetic reduced graphene oxide coated collagen scaffold for in situ bone regeneration. Sci. Rep. 2021, 11, 16783. [Google Scholar] [CrossRef]
  51. Fu, C.; Jiang, Y.; Yang, X.; Wang, Y.; Ji, W.; Jia, G. Mussel-Inspired Gold Nanoparticle and PLGA/L-Lysine-g-Graphene Oxide Composite Scaffolds for Bone Defect Repair. Int. J. Nanomed. 2021, 16, 6693–6718. [Google Scholar] [CrossRef] [PubMed]
  52. Kim, J.; Kim, H.D.; Park, J.; Lee, E.S.; Kim, E.; Lee, S.S.; Yang, J.K.; Lee, Y.S.; Hwang, N.S. Enhanced osteogenic commitment of murine mesenchymal stem cells on graphene oxide substrate. Biomater. Res. 2018, 22, 1. [Google Scholar] [CrossRef] [PubMed]
  53. O’Neill, E.; Awale, G.; Daneshmandi, L.; Umerah, O.; Lo, K.W. The roles of ions on bone regeneration. Drug Discov. Today 2018, 23, 879–890. [Google Scholar] [CrossRef]
  54. Arnold, A.M.; Holt, B.D.; Daneshmandi, L.; Laurencin, C.T.; Sydlik, S.A. Phosphate graphene as an intrinsically osteoinductive scaffold for stem cell-driven bone regeneration. Proc. Natl. Acad. Sci. USA 2019, 116, 4855–4860. [Google Scholar] [CrossRef] [PubMed]
  55. Song, F.; Jiang, D.; Wang, T.; Wang, Y.; Lou, Y.; Zhang, Y.; Ma, H.; Kang, Y. Mechanical Stress Regulates Osteogenesis and Adipogenesis of Rat Mesenchymal Stem Cells through PI3K/Akt/GSK-3β/β-Catenin Signaling Pathway. Biomed. Res. Int. 2017, 2017, 6027402. [Google Scholar] [CrossRef] [PubMed]
  56. Newby, S.D.; Masi, T.; Griffin, C.D.; King, W.J.; Chipman, A.; Stephenson, S.; Anderson, D.E.; Biris, A.S.; Bourdo, S.E.; Dhar, M. Functionalized Graphene Nanoparticles Induce Human Mesenchymal Stem Cells to Express Distinct Extracellular Matrix Proteins Mediating Osteogenesis. Int. J. Nanomed. 2020, 15, 2501–2513. [Google Scholar] [CrossRef]
  57. Felgueiras, H.P.; Evans, M.D.M.; Migonney, V. Contribution of fibronectin and vitronectin to the adhesion and morphology of MC3T3-E1 osteoblastic cells to poly(NaSS) grafted Ti6Al4V. Acta Biomater. 2015, 28, 225–233. [Google Scholar] [CrossRef]
  58. Steward, A.J.; Kelly, D.J. Mechanical regulation of mesenchymal stem cell differentiation. J. Anat. 2015, 227, 717–731. [Google Scholar] [CrossRef]
  59. Mathieu, P.S.; Loboa, E.G. Cytoskeletal and focal adhesion influences on mesenchymal stem cell shape, mechanical properties, and differentiation down osteogenic, adipogenic, and chondrogenic pathways. Tissue Eng. Part B Rev. 2012, 18, 436–444. [Google Scholar] [CrossRef]
  60. Gallorini, M.; Zara, S.; Ricci, A.; Mangano, F.G.; Cataldi, A.; Mangano, C. The Open Cell Form of 3D-Printed Titanium Improves Osteconductive Properties and Adhesion Behavior of Dental Pulp Stem Cells. Materials 2021, 14, 5308. [Google Scholar] [CrossRef]
  61. Kim, H.D.; Kim, J.; Koh, R.H.; Shim, J.; Lee, J.C.; Kim, T.I.; Hwang, N.S. Enhanced Osteogenic Commitment of Human Mesenchymal Stem Cells on Polyethylene Glycol-Based Cryogel with Graphene Oxide Substrate. ACS Biomater. Sci. Eng. 2017, 3, 2470–2479. [Google Scholar] [CrossRef] [PubMed]
  62. Xie, H.; Cao, T.; Franco-Obregón, A.; Rosa, V. Graphene-Induced Osteogenic Differentiation Is Mediated by the Integrin/FAK Axis. Int. J. Mol. Sci. 2019, 20, 574. [Google Scholar] [CrossRef] [PubMed]
  63. Li, Q.; Wang, Z. Involvement of FAK/P38 Signaling Pathways in Mediating the Enhanced Osteogenesis Induced by Nano-Graphene Oxide Modification on Titanium Implant Surface. Int. J. Nanomed. 2020, 15, 4659–4676. [Google Scholar] [CrossRef]
  64. Tahriri, M.; Del Monico, M.; Moghanian, A.; Tavakkoli Yaraki, M.; Torres, R.; Yadegari, A.; Tayebi, L. Graphene and its derivatives: Opportunities and challenges in dentistry. Mater. Sci. Eng. C Mater. Biol. Appl. 2019, 102, 171–185. [Google Scholar] [CrossRef] [PubMed]
  65. Di Carlo, R.; Zara, S.; Ventrella, A.; Siani, G.; Da Ros, T.; Iezzi, G.; Cataldi, A.; Fontana, A. Covalent Decoration of Cortical Membranes with Graphene Oxide as a Substrate for Dental Pulp Stem Cells. Nanomaterials 2019, 9, 604. [Google Scholar] [CrossRef]
  66. Di Crescenzo, A.; Zara, S.; Di Nisio, C.; Ettorre, V.; Ventrella, A.; Zavan, B.; Di Profio, P.; Cataldi, A.; Fontana, A. Graphene Oxide Foils as an Osteoinductive Stem Cell Substrate. ACS Appl. Bio Mater. 2019, 2, 1643–1651. [Google Scholar] [CrossRef]
  67. Yang, N.; Liu, Y. The Role of the Immune Microenvironment in Bone Regeneration. Int. J. Med. Sci. 2021, 18, 3697–3707. [Google Scholar] [CrossRef] [PubMed]
  68. He, J.; Chen, G.; Liu, M.; Xu, Z.; Chen, H.; Yang, L.; Lv, Y. Scaffold strategies for modulating immune microenvironment during bone regeneration. Mater. Sci. Eng. C Mater. Biol. Appl. 2020, 108, 110411. [Google Scholar] [CrossRef]
  69. Omar, O.M.; Granéli, C.; Ekström, K.; Karlsson, C.; Johansson, A.; Lausmaa, J.; Wexell, C.L.; Thomsen, P. The stimulation of an osteogenic response by classical monocyte activation. Biomaterials 2011, 32, 8190–8204. [Google Scholar] [CrossRef][Green Version]
  70. Bordoni, V.; Reina, G.; Orecchioni, M.; Furesi, G.; Thiele, S.; Gardin, C.; Zavan, B.; Cuniberti, G.; Bianco, A.; Rauner, M.; et al. Stimulation of bone formation by monocyte-activator functionalized graphene oxide in vivo. Nanoscale 2019, 11, 19408–19421. [Google Scholar] [CrossRef]
  71. Su, J.; Du, Z.; Xiao, L.; Wei, F.; Yang, Y.; Li, M.; Qiu, Y.; Liu, J.; Chen, J.; Xiao, Y. Graphene oxide coated Titanium Surfaces with Osteoimmunomodulatory Role to Enhance Osteogenesis. Mater. Sci. Eng. C Mater. Biol. Appl. 2020, 113, 110983. [Google Scholar] [CrossRef] [PubMed]
  72. Chang, T.K.; Lu, Y.C.; Yeh, S.T.; Lin, T.C.; Huang, C.H.; Huang, C.H. In vitro and in vivo Biological Responses to Graphene and Graphene Oxide: A Murine Calvarial Animal Study. Int. J. Nanomed. 2020, 15, 647–659. [Google Scholar] [CrossRef] [PubMed]
  73. Simon, T.M.; Jackson, D.W. Articular Cartilage: Injury Pathways and Treatment Options. Sports Med. Arthrosc. Rev. 2018, 26, 31–39. [Google Scholar] [CrossRef] [PubMed]
  74. Armiento, A.R.; Stoddart, M.J.; Alini, M.; Eglin, D. Biomaterials for articular cartilage tissue engineering: Learning from biology. Acta Biomater. 2018, 65, 1–20. [Google Scholar] [CrossRef] [PubMed]
  75. Solchaga, L.A.; Penick, K.J.; Welter, J.F. Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: Tips and tricks. Methods Mol. Biol. 2011, 698, 253–278. [Google Scholar]
  76. Shen, H.; Lin, H.; Sun, A.X.; Song, S.; Zhang, Z.; Dai, J.; Tuan, R.S. Chondroinductive factor-free chondrogenic differentiation of human mesenchymal stem cells in graphene oxide-incorporated hydrogels. J. Mater. Chem. B 2018, 6, 908–917. [Google Scholar] [CrossRef]
  77. Pogue, R.; Lyons, K. BMP signaling in the cartilage growth plate. Curr. Top. Dev. Biol. 2006, 76, 1–48. [Google Scholar]
  78. Song, B.; Estrada, K.D.; Lyons, K.M. Smad signaling in skeletal development and regeneration. Cytokine Growth Factor Rev. 2009, 20, 379–388. [Google Scholar] [CrossRef]
  79. Mueller, M.B.; Fischer, M.; Zellner, J.; Berner, A.; Dienstknecht, T.; Prantl, L.; Kujat, R.; Nerlich, M.; Tuan, R.S.; Angele, P. Hypertrophy in mesenchymal stem cell chondrogenesis: Effect of TGF-beta isoforms and chondrogenic conditioning. Cells Tissues Organs 2010, 192, 158–166. [Google Scholar] [CrossRef]
  80. Deliormanlı, A.M. Direct Write Assembly of Graphene/Poly(ε-Caprolactone) Composite Scaffolds and Evaluation of Their Biological Performance Using Mouse Bone Marrow Mesenchymal Stem Cells. Appl. Biochem. Biotechnol. 2019, 188, 1117–1133. [Google Scholar] [CrossRef]
  81. Olate-Moya, F.; Arens, L.; Wilhelm, M.; Mateos-Timoneda, M.A.; Engel, E.; Palza, H. Chondroinductive Alginate-Based Hydrogels Having Graphene Oxide for 3D Printed Scaffold Fabrication. ACS Appl. Mater. Interfaces 2020, 12, 4343–4357. [Google Scholar] [CrossRef] [PubMed]
  82. Lee, K.; Silva, E.A.; Mooney, D.J. Growth factor delivery-based tissue engineering: General approaches and a review of recent developments. J. R. Soc. Interface 2011, 8, 153–170. [Google Scholar] [CrossRef] [PubMed]
  83. Silva, A.K.; Richard, C.; Bessodes, M.; Scherman, D.; Merten, O.W. Growth factor delivery approaches in hydrogels. Biomacromolecules 2009, 10, 9–18. [Google Scholar] [CrossRef] [PubMed]
  84. Yoon, H.H.; Bhang, S.H.; Kim, T.; Yu, T.; Hyeon, T.; Kim, B.S. Dual roles of graphene oxide in chondrogenic differentiation of adult stem cells: Cell-adhesion substrate and growth factor-delivery carrier. Adv. Funct. Mater. 2014, 24, 6455–6464. [Google Scholar] [CrossRef]
  85. Zhou, M.; Lozano, N.; Wychowaniec, J.K.; Hodgkinson, T.; Richardson, S.M.; Kostarelos, K.; Hoyland, J.A. Graphene oxide: A growth factor delivery carrier to enhance chondrogenic differentiation of human mesenchymal stem cells in 3D hydrogels. Acta Biomater. 2019, 96, 271–280. [Google Scholar] [CrossRef]
  86. Jiao, D.; Wang, J.; Yu, W.; Zhang, N.; Zhang, K.; Bai, Y. Gelatin reduced Graphene Oxide Nanosheets as Kartogenin Nanocarrier Induces Rat ADSCs Chondrogenic Differentiation Combining with Autophagy Modification. Materials 2021, 14, 1053. [Google Scholar] [CrossRef]
  87. Cai, G.; Liu, W.; He, Y.; Huang, J.; Duan, L.; Xiong, J.; Liu, L.; Wang, D. Recent advances in kartogenin for cartilage regeneration. J. Drug Target. 2019, 27, 28–32. [Google Scholar] [CrossRef]
Materials 15 02229 g001
Figure 1. Chemical structure of graphene and graphene oxide.
Figure 1. Chemical structure of graphene and graphene oxide.
Materials 15 02229 g001
Materials 15 02229 g002
Figure 2. Biomedical applications of GO. (A) Among others, GO is used in phototherapy, cancer treatments, drug and gene delivery, and inflammation treatment. (B) Application of GO in tissue engineering and stem cell differentiation as osteoconductive and chondroinductive material [28].
Figure 2. Biomedical applications of GO. (A) Among others, GO is used in phototherapy, cancer treatments, drug and gene delivery, and inflammation treatment. (B) Application of GO in tissue engineering and stem cell differentiation as osteoconductive and chondroinductive material [28].
Materials 15 02229 g002
Materials 15 02229 g003
Figure 3. Osteoinductive properties of GO. Graphene enhances the osteogenic process by interacting with biomacromolecules through its π-electron cloud. In addition, GO is able to trigger cell-adhesion-related molecular pathways. FAK = focal adhesion kinase; SMAD1 = small mothers against decapentaplegic-1; ROCK = Rho-associated protein kinase; RhoA = Ras homologous GTPase; RUNX2 = runt-related transcription factor 2; OPN = osteopontin; OCN = osteocalcin.
Figure 3. Osteoinductive properties of GO. Graphene enhances the osteogenic process by interacting with biomacromolecules through its π-electron cloud. In addition, GO is able to trigger cell-adhesion-related molecular pathways. FAK = focal adhesion kinase; SMAD1 = small mothers against decapentaplegic-1; ROCK = Rho-associated protein kinase; RhoA = Ras homologous GTPase; RUNX2 = runt-related transcription factor 2; OPN = osteopontin; OCN = osteocalcin.
Materials 15 02229 g003
Materials 15 02229 g004
Figure 4. Effect of graphene on the immune system. Under the influence of graphene-coated materials, macrophages change their phenotype from the pro-inflammatory M1 to the anti-inflammatory M2 one, promoting tissue repair (osteogenesis). MSCs = mesenchymal stem cells.
Figure 4. Effect of graphene on the immune system. Under the influence of graphene-coated materials, macrophages change their phenotype from the pro-inflammatory M1 to the anti-inflammatory M2 one, promoting tissue repair (osteogenesis). MSCs = mesenchymal stem cells.
Materials 15 02229 g004
Materials 15 02229 g005
Figure 5. Chondroinductive properties of GO. Graphene oxide promotes chondrogenesis without the addition of conventional chondrogenic differentiation factors in growth media. In parallel, it can enhance chondrogenesis, thus helping to release differentiation factors from biomaterials in a controlled manner. TGF-β1 = transforming growth factor beta 1; TGF-β3 = transforming growth factor beta 3; MSCs = mesenchymal stem cells.
Figure 5. Chondroinductive properties of GO. Graphene oxide promotes chondrogenesis without the addition of conventional chondrogenic differentiation factors in growth media. In parallel, it can enhance chondrogenesis, thus helping to release differentiation factors from biomaterials in a controlled manner. TGF-β1 = transforming growth factor beta 1; TGF-β3 = transforming growth factor beta 3; MSCs = mesenchymal stem cells.
Materials 15 02229 g005
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ricci, A.; Cataldi, A.; Zara, S.; Gallorini, M. Graphene-Oxide-Enriched Biomaterials: A Focus on Osteo and Chondroinductive Properties and Immunomodulation. Materials 2022, 15, 2229. https://doi.org/10.3390/ma15062229

AMA Style

Ricci A, Cataldi A, Zara S, Gallorini M. Graphene-Oxide-Enriched Biomaterials: A Focus on Osteo and Chondroinductive Properties and Immunomodulation. Materials. 2022; 15(6):2229. https://doi.org/10.3390/ma15062229

Chicago/Turabian Style

Ricci, Alessia, Amelia Cataldi, Susi Zara, and Marialucia Gallorini. 2022. "Graphene-Oxide-Enriched Biomaterials: A Focus on Osteo and Chondroinductive Properties and Immunomodulation" Materials 15, no. 6: 2229. https://doi.org/10.3390/ma15062229

APA Style

Ricci, A., Cataldi, A., Zara, S., & Gallorini, M. (2022). Graphene-Oxide-Enriched Biomaterials: A Focus on Osteo and Chondroinductive Properties and Immunomodulation. Materials, 15(6), 2229. https://doi.org/10.3390/ma15062229

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop